Rate and rhythm control in atrial fibrillation. Pharmacological approaches

被引：0
作者：
Weipert, K. F. [1 ]
Erkapic, D. [1 ]
Schmitt, J. [1 ]
机构：
[1] Univ Klin Giessen, Med Klin Kardiol 1, D-35392 Giessen, Germany
来源：
HERZ | 2015年 / 40卷 / 01期
关键词：
Atrial fibrillation; Pharmacological therapy; Antiarrhythmic agents; Rate control; Rhythm control; LONG-QT-SYNDROME; QUALITY-OF-LIFE; INTRAVENOUS AMIODARONE; EUROPEAN HEART; SINUS RHYTHM; CARDIOVERSION; CONVERSION; DRONEDARONE; WARFARIN; EFFICACY;
D O I：
10.1007/s00059-014-4201-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Atrial fibrillation is the most common form of cardiac arrhythmia, occurring in 1-2 % of the population and due to an increased life expectancy the prevalence will increase further. Pharmacological treatment of atrial fibrillation is an important component of basic initial therapeutic options for patients with atrial fibrillation. Independent of an individually adjusted prevention of thromboembolism, rate and rhythm management can also be carried out. While rate control mainly applies to all patients, rhythm control is only indicated in patients who remain clinically symptomatic despite sufficient rate control. Profound knowledge about antiarrhythmic drugs including specific interactions is necessary due to the variable individual effects and sometimes severe side effects.
引用
收藏
页码：16 / 24
页数：9
相关论文
共 61 条
[1]   Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket'' approach [J].
Alboni, P ;
Botto, GL ;
Baldi, N ;
Luzi, M ;
Russo, V ;
Gianfranchi, L ;
Marchi, P ;
Calzolari, M ;
Solano, A ;
Baroffio, R ;
Gaggioli, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (23) :2384-2391
[2]   2012 focused update of the ESC Guidelines for the management of atrial fibrillation (vol 33, pg 2719, 2012) [J].
Camm, A. John ;
Lip, Gregory Y. H. ;
De Caterina, Raffaele ;
Savelieva, Irene ;
Atar, Dan ;
Hohnloser, Stefan H. ;
Hindricks, Gerhard ;
Kirchhof, Paulus .
EUROPEAN HEART JOURNAL, 2013, 34 (10) :790-790
[3]   2012 focused update of the ESC Guidelines for the management of atrial fibrillation [J].
Camm, A. John ;
Lip, Gregory Y. H. ;
De Caterina, Raffaele ;
Savelieva, Irene ;
Atar, Dan ;
Hohnloser, Stefan H. ;
Hindricks, Gerhard ;
Kirchhof, Paulus ;
Bax, Jeroen J. ;
Baumgartner, Helmut ;
Ceconi, Claudio ;
Dean, Veronica ;
Deaton, Christi ;
Fagard, Robert ;
Funck-Brentano, Christian ;
Hasdai, David ;
Hoes, Arno ;
Knuuti, Juhani ;
Kolh, Philippe ;
McDonagh, Theresa ;
Moulin, Cyril ;
Popescu, Bogdan A. ;
Reiner, Zeljko ;
Sechtem, Udo ;
Sirnes, Per Anton ;
Tendera, Michal ;
Torbicki, Adam ;
Vahanian, Alec ;
Windecker, Stephan ;
Vardas, Panos ;
Al-Attar, Nawwar ;
Alfieri, Ottavio ;
Angelini, Annalisa ;
Blomstrom-Lundqvist, Carina ;
Colonna, Paolo ;
De Sutter, Johan ;
Ernst, Sabine ;
Goette, Andreas ;
Gorenek, Bulent ;
Hatala, Robert ;
Heidbuchel, Hein ;
Heldal, Magnus ;
Kristensen, Steen Dalby ;
Le Heuzey, Jean-Yves ;
Mavrakis, Hercules ;
Mont, Lluis ;
Filardi, Pasquale Perrone ;
Ponikowski, Piotr ;
Prendergast, Bernard ;
Rutten, Frans H. .
EUROPEAN HEART JOURNAL, 2012, 33 (21) :2719-2747
[4]   A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation [J].
Camm, A. John ;
Capucci, Alessandro ;
Hohnloser, Stefan H. ;
Torp-Pedersen, Christian ;
Van Gelder, Isabelle C. ;
Mangal, Brian ;
Beatch, Gregory .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (03) :313-321
[5]  
Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
[6]   Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation [J].
Cappato, Riccardo ;
Ezekowitz, Michael D. ;
Klein, Allan L. ;
Camm, A. John ;
Ma, Chang-Sheng ;
Le Heuzey, Jean-Yves ;
Talajic, Mario ;
Scanavacca, Mauricio ;
Vardas, Panos E. ;
Kirchhof, Paulus ;
Hemmrich, Melanie ;
Lanius, Vivian ;
LingMeng, Isabelle ;
Wildgoose, Peter ;
van Eickels, Martin ;
Hohnloser, Stefan H. .
EUROPEAN HEART JOURNAL, 2014, 35 (47) :3346-3355
[7]   Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation - The Strategies of Treatment of Atrial Fibrillation (STAF) study [J].
Carlsson, J ;
Miketic, S ;
Windeler, J ;
Cuneo, A ;
Haun, S ;
Micus, S ;
Walter, S ;
Tebbe, U .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1690-1696
[8]   Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: A prospective single-center experience [J].
Chun, K. R. Julian ;
Bordignon, Stefano ;
Urban, Verena ;
Perrotta, Laura ;
Dugo, Daniela ;
Fuernkranz, Alexander ;
Nowak, Bernd ;
Schmidt, Boris .
HEART RHYTHM, 2013, 10 (12) :1792-1799
[9]   Intravenous Amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias [J].
Clemo, HF ;
Wood, MA ;
Gilligan, DM ;
Ellenbogen, KA .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (05) :594-598
[10]   Evidence-based analysis of amiodarone efficacy and safety [J].
Connolly, SJ .
CIRCULATION, 1999, 100 (19) :2025-2034
1234567